Glenmark to introduce SGLT2 inhibitor Remogliflozin in India by licesning collaboration with BHV Pharma
Glenmark Pharmaceuticals is bringing to India Remogliflozin etabonate, a drug used to treat adults with Type 2 diabetes. Glenmark did the phase... Read More